Maya Frutiger
Head of Corporate Communications
maya.frutiger@us.sumitomo-pharma.com
News Releases
Stay up to date with SMPA
The latest company news, press releases, and resources about Sumitomo Pharma America, our employees, our partners, and our latest innovations.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 29, 2020
MARLBOROUGH, Mass., June 29, 2021 at 9:00 AM EDT (BUSINESS WIRE) — Sunovion Pharmaceuticals Inc. (Sunovion) today announced topline results from study SEP380-201, a global, multicenter,...
-
May 29, 2020•Phase 3 data presented in oral presentation during the ASCO20 Virtual Scientific Program, with simultaneous publication in the New England Journal of Medicine
BASEL, Switzerland, May 29, 2020 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced additional results from...
-
Apr 15, 2020—Significantly greater improvement in the Positive and Negative Symptom Scale was demonstrated in schizophrenia patients treated with SEP-363856, a TAAR1 agonist, compared to placebo—
MARLBOROUGH, Mass., April 15, 2020 5:04 pm (BUSINESS WIRE) — Sunovion Pharmaceuticals Inc. (Sunovion) today announced that results of a four-week pivotal study (SEP361-201) evaluating the safety...
-
Mar 31, 2020•Gedeon Richter to commercialize relugolix combination tablet for uterine fibroids and endometriosis in Europe, Russia – CIS, Latin America, Australia, and New Zealand
BASEL, Switzerland and BUDAPEST, Hungary, March 31, 2020 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women’s health...